Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between the G75A polymorphism in the apolipoprotein A1 (ApoA1) gene and the lipid regulatory effects of pravastatin in patients with hyperlipidemia.

Genetics and molecular research : GMR - 17 Jun 2016

Liu T N, Wu C T, He F, Yuan W, Li S X, Li H W, Yu H Y, Wu M

Abstract excerpt

In this study, we investigated the relationship between the G75A polymorphism in the apolipoprotein A1 (ApoA1) gene and the lipid regulatory effect of pravastatin in patients with hyperlipidemia. A total of 179 patients were divided into two groups: the pravastatin (N = 97) and policosanol (N = 82) treatment groups. The total cholesterol (TC), triglyceride, low-density lipoprotein (LDL-c), high-density...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Apolipoprotein A-I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperlipidemias

Share to Lipoproteins

Share to Polymorphism, Single Nucleotide

Share to Pravastatin

Source

Identifiers

PMID: 27323196
DOI: 10.4238/gmr.15028216

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between the G75A polymorphism in the apolipoprotein A1 (ApoA1) gene and the lipid regulatory effects of pravastatin in patients with hyperlipidemia.PMID 27323196Read ↗

Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.Semantic proximity Read ↗

Association of polymorphisms of ApoE, ApoA1, PCSK9 with LDL-C modification following Atorvastatin therapy in dyslipidemic patients.Semantic proximity Read ↗

Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.Semantic proximity Read ↗

[Association between apolipoprotein A1-75 bp gene polymorphisms and risk for dyslipidemia and coronary artery disease].Semantic proximity Read ↗

[Effects of ApoE gene polymorphism on the efficacy of atorvastatin in the treatment of hyperlipidemia].Semantic proximity Read ↗

CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.Semantic proximity Read ↗

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.Semantic proximity Read ↗

Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease.Semantic proximity Read ↗

Pharmacogenomic importance of pravastatin.Semantic proximity Read ↗

Association of HMGCR rs17671591 and rs3761740 with lipidemia and statin response in Uyghurs and Han Chinese.Semantic proximity Read ↗

APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals.Semantic proximity Read ↗

Associations of Two Common Polymorphisms in MTHFR Gene with Blood Lipids and Therapeutic Efficacy of Simvastatin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.